Cooperative Agreement NH28CE002757

Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $1,091,599 to the Research Foundation For Mental Hygiene, Inc. (through its New York State Psychiatric Institute division) on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test E-CONNECTYA, a tailored system-level intervention designed to improve identification and treatment engagement for overdose risk, suicide, and behavioral health problems among...

The Connecticut Department of Mental Health and Addiction Services (DMHAS) was awarded a $7,000,000 Project Grant under the Comprehensive Opioid, Stimulant, and other Substances Use Program (COSSUP) by the U.S. Department of Justice's Bureau of Justice Assistance (CFDA 16.838). The grant, effective October 1, 2024 through September 30, 2027, aims to bolster community-based opioid overdose response efforts in Western Connecticut. Key activities include integrating best practices such as...

The Hancock County Alcohol, Drug Addiction and Mental Health Services (ADAMHS) Board was awarded a $1 million Project Grant from the Department of Justice Office of Justice Programs Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and other Substances Use Program (COSSUP) to develop a comprehensive, multi-disciplinary collaborative approach to address and prevent illicit substance use and its adverse consequences in a predominantly rural county. The Criminal Justice...

Federal Grant Award Summary Rhode Island Hospital has received a $764,165 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the CONNECT program, a digital intervention designed to increase engagement in HIV and substance use disorder care among survivors of sex trafficking. The award, effective July 1, 2025 through June 30, 2028, supports the development of an evidence-based intervention that...

The Altarum Institute, in partnership with Faces & Voices of Recovery and Change Matrix, was awarded a $2,500,000 Cooperative Agreement by the U.S. Department of Justice's Bureau of Justice Assistance (CFDA 16.838 Comprehensive Opioid, Stimulant, and other Substances Use Program) to serve as the Category 2A Training and Technical Assistance (TTA) Center for Access to Treatment, Peer Recovery, and other Recovery Support Services. The TTA Center will assist COSSUP grantees and the broader...

The Bureau of Justice Assistance (BJA) awarded a $1,300,000 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) grant to the City of Long Beach, California. The grant will fund the expansion of the city's Law Enforcement Assisted Diversion (LEAD) model by creating a Field-Based Care Coordination Team (CCT) to increase participant enrollment, connect participants to treatment, and reduce recidivism. Key components of the project include establishing a partnership with the Los...

Grant Award Summary The University of California, San Diego received a $150,104 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct secondary data analysis investigating developmental brain connectomes and substance use in adolescence. The award, effective January 30, 2026 through August 14, 2027, supports research examining how nicotine and tobacco product use impact structural and functional brain networks...

The Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment awarded $42.12 million to the Administracion De Servicios De Salud Mental Y Contra La Adiccion (Assmca) under the Substance Use Prevention, Treatment, and Recovery Services Block Grant (CFDA 93.959) for the period October 1, 2025 through September 30, 2027. As Puerto Rico's designated territorial substance abuse authority, Assmca will utilize these funds to support comprehensive...

The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded $1.25M to the Burnett County Law Enforcement Citizens Auxiliary Inc. under CFDA 93.243 (Substance Abuse and Mental Health Services Projects of Regional and National Significance) on September 30, 2025, for a five-year project period through September 29, 2030. The Youth of Burnett County Prevention Coalition (YBCPC) will deliver community-based substance use prevention services across rural northwest Wisconsin,...

Federal Cooperative Agreement Summary The National Institute on Drug Abuse (NIDA) awarded Lovelace Biomedical Research Institute a $1.8M cooperative agreement (CFDA 93.279: Drug Use and Addiction Research Programs) effective September 30, 2025, through August 31, 2027, to research the application of neuromodulation technology to enhance substance use disorder (SUD) treatment efficacy. The primary deliverable involves investigating transcranial alternating current stimulation (tACS)—a...